Living in Limbo: Managing Risk, Care, and Clarity with a Precursor Condition
Being diagnosed with a blood cancer precursor like MGUS, SMM, CHIP, CCUS, MDS/MPNs, can feel like living in medical limbo. In this session, Dr. Tremblay from Mount Sinai will address key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials. Whether you’re newly diagnosed or monitoring your condition over time, this webinar will help you better understand your diagnosis and confidently navigate what comes next.
Mary introduces the agenda and our featured speaker Dr. Douglas Tremblay
Dr. Douglas Tremblay talks about key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials
Come with your questions and we will answer them!
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Douglas Tremblay, MD
Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Dr. Tremblay specializes in hematologic malignancies including acute myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.